Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03260322
Brief Title: A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

First Submitted : August 22, 2017
First Submitted that Met QC Criteria : August 22, 2017
First Posted : August 24, 2017

Last Update Submitted that Met QC Criteria : April 8, 2020
Last Update Posted : April 9, 2020